α-methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues

Bin Ouyang, Yuet Kin Leung, Vinson Wang, Ethan Chung, Linda Levin, Bruce Bracken, Liang Cheng, Shuk Mei Ho

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objectives: To evaluate the possibility of using α-methylacyl-CoA racemase (AMACR) variants to improve the specificity of prostate cancer (CaP) detection. AMACR has been used as a diagnostic biomarker for CaP and is now a standard biomarker for needle biopsy specimens with ambiguous lesions. Methods: We used in silico analysis and molecular cloning to discover new AMACR variants and quantitative reverse transcriptionpolymerase chain reaction (RT-PCR) to measure the transcript levels of AMACR and its variants in 4 prostate cell lines and in 23 pairs of CaP and adjacent normal tissue. Results: We found 4 novel variants, IAs, IBL, IBLd, and IBLi. Transcript levels of most AMACR variants were significantly upregulated in CaP compared with its adjacent normal counterparts. A variants, the functional variants based on bioinformatic analysis, showed levels of transcript expression in CaP in this order: IA≫IAd=IIA≫IIAs>IAs. In contrast, the expression of the B variants, which appear to be nonfunctional due to the absence of exon 3, was lower than that of the A variants. IB was the most abundant form of B variant; and expression of IIB was negligible. More important, the difference between levels of variant IA, IAd, IIA, IIAs, IB, and IBLi in CaP and normal tissue was significantly higher than the difference in levels of total AMACR. Conclusions: Our data suggest that AMACR variants have better power than total AMACR in discriminating between CaP and adjacent normal tissue. These findings may be useful for the development of future diagnostic assays.

Original languageEnglish
JournalUrology
Volume77
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Racemases and Epimerases
Coenzyme A
Prostate
Biomarkers
Molecular Cloning
Needle Biopsy
Computational Biology
Computer Simulation
Exons
Prostatic Neoplasms
Cell Line

ASJC Scopus subject areas

  • Urology

Cite this

α-methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues. / Ouyang, Bin; Leung, Yuet Kin; Wang, Vinson; Chung, Ethan; Levin, Linda; Bracken, Bruce; Cheng, Liang; Ho, Shuk Mei.

In: Urology, Vol. 77, No. 1, 01.2011.

Research output: Contribution to journalArticle

Ouyang, Bin ; Leung, Yuet Kin ; Wang, Vinson ; Chung, Ethan ; Levin, Linda ; Bracken, Bruce ; Cheng, Liang ; Ho, Shuk Mei. / α-methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues. In: Urology. 2011 ; Vol. 77, No. 1.
@article{2f3560ccccd947fd8bf6dd3f3eb9888e,
title = "α-methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues",
abstract = "Objectives: To evaluate the possibility of using α-methylacyl-CoA racemase (AMACR) variants to improve the specificity of prostate cancer (CaP) detection. AMACR has been used as a diagnostic biomarker for CaP and is now a standard biomarker for needle biopsy specimens with ambiguous lesions. Methods: We used in silico analysis and molecular cloning to discover new AMACR variants and quantitative reverse transcriptionpolymerase chain reaction (RT-PCR) to measure the transcript levels of AMACR and its variants in 4 prostate cell lines and in 23 pairs of CaP and adjacent normal tissue. Results: We found 4 novel variants, IAs, IBL, IBLd, and IBLi. Transcript levels of most AMACR variants were significantly upregulated in CaP compared with its adjacent normal counterparts. A variants, the functional variants based on bioinformatic analysis, showed levels of transcript expression in CaP in this order: IA≫IAd=IIA≫IIAs>IAs. In contrast, the expression of the B variants, which appear to be nonfunctional due to the absence of exon 3, was lower than that of the A variants. IB was the most abundant form of B variant; and expression of IIB was negligible. More important, the difference between levels of variant IA, IAd, IIA, IIAs, IB, and IBLi in CaP and normal tissue was significantly higher than the difference in levels of total AMACR. Conclusions: Our data suggest that AMACR variants have better power than total AMACR in discriminating between CaP and adjacent normal tissue. These findings may be useful for the development of future diagnostic assays.",
author = "Bin Ouyang and Leung, {Yuet Kin} and Vinson Wang and Ethan Chung and Linda Levin and Bruce Bracken and Liang Cheng and Ho, {Shuk Mei}",
year = "2011",
month = "1",
doi = "10.1016/j.urology.2010.08.005",
language = "English",
volume = "77",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - α-methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues

AU - Ouyang, Bin

AU - Leung, Yuet Kin

AU - Wang, Vinson

AU - Chung, Ethan

AU - Levin, Linda

AU - Bracken, Bruce

AU - Cheng, Liang

AU - Ho, Shuk Mei

PY - 2011/1

Y1 - 2011/1

N2 - Objectives: To evaluate the possibility of using α-methylacyl-CoA racemase (AMACR) variants to improve the specificity of prostate cancer (CaP) detection. AMACR has been used as a diagnostic biomarker for CaP and is now a standard biomarker for needle biopsy specimens with ambiguous lesions. Methods: We used in silico analysis and molecular cloning to discover new AMACR variants and quantitative reverse transcriptionpolymerase chain reaction (RT-PCR) to measure the transcript levels of AMACR and its variants in 4 prostate cell lines and in 23 pairs of CaP and adjacent normal tissue. Results: We found 4 novel variants, IAs, IBL, IBLd, and IBLi. Transcript levels of most AMACR variants were significantly upregulated in CaP compared with its adjacent normal counterparts. A variants, the functional variants based on bioinformatic analysis, showed levels of transcript expression in CaP in this order: IA≫IAd=IIA≫IIAs>IAs. In contrast, the expression of the B variants, which appear to be nonfunctional due to the absence of exon 3, was lower than that of the A variants. IB was the most abundant form of B variant; and expression of IIB was negligible. More important, the difference between levels of variant IA, IAd, IIA, IIAs, IB, and IBLi in CaP and normal tissue was significantly higher than the difference in levels of total AMACR. Conclusions: Our data suggest that AMACR variants have better power than total AMACR in discriminating between CaP and adjacent normal tissue. These findings may be useful for the development of future diagnostic assays.

AB - Objectives: To evaluate the possibility of using α-methylacyl-CoA racemase (AMACR) variants to improve the specificity of prostate cancer (CaP) detection. AMACR has been used as a diagnostic biomarker for CaP and is now a standard biomarker for needle biopsy specimens with ambiguous lesions. Methods: We used in silico analysis and molecular cloning to discover new AMACR variants and quantitative reverse transcriptionpolymerase chain reaction (RT-PCR) to measure the transcript levels of AMACR and its variants in 4 prostate cell lines and in 23 pairs of CaP and adjacent normal tissue. Results: We found 4 novel variants, IAs, IBL, IBLd, and IBLi. Transcript levels of most AMACR variants were significantly upregulated in CaP compared with its adjacent normal counterparts. A variants, the functional variants based on bioinformatic analysis, showed levels of transcript expression in CaP in this order: IA≫IAd=IIA≫IIAs>IAs. In contrast, the expression of the B variants, which appear to be nonfunctional due to the absence of exon 3, was lower than that of the A variants. IB was the most abundant form of B variant; and expression of IIB was negligible. More important, the difference between levels of variant IA, IAd, IIA, IIAs, IB, and IBLi in CaP and normal tissue was significantly higher than the difference in levels of total AMACR. Conclusions: Our data suggest that AMACR variants have better power than total AMACR in discriminating between CaP and adjacent normal tissue. These findings may be useful for the development of future diagnostic assays.

UR - http://www.scopus.com/inward/record.url?scp=78650853321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650853321&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2010.08.005

DO - 10.1016/j.urology.2010.08.005

M3 - Article

VL - 77

JO - Urology

JF - Urology

SN - 0090-4295

IS - 1

ER -